EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Correlates of APOBEC ‐Associated Mutagenesis in Esophageal Squamous Cell Carcinoma

Emmanuel Owusu Ansah iD, Joshua Ampofo Yentumi iD, Emmanuel Yeboah Kodom, Prince Owusu Mensah, Kwadwo Fosu, Isaac Kofi Adu, Emmanuel Adu Boahen

Molecular Genetics & Genomic Medicine · 2026-11 · 14 (11)

DOI: 10.1002/mgg3.70345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 09.11.2026. Verfasst von Emmanuel Owusu Ansah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Biotechnology, University of Cape Coast, Cape Coast, Ghana. Hauptthemen laut MEDLINE: Mutagenesis, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, APOBEC Deaminases. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims APOBEC‐associated mutagenesis is prominent in esophageal squamous cell carcinoma (ESCC), but genomic features associated with its intertumoral variability remain incompletely characterized. We investigated genomic correlates of APOBEC‐associated mutagenesis while accounting for the compositional structure of mutational signature data.

Methods

Mutational signatures were analyzed in 552 ESCC tumors from eight countries. APOBEC‐associated mutagenesis was quantified as SBS2 plus SBS13 using absolute mutation counts and proportional contributions. Associations with co‐occurring mutational signatures, total SBS burden, recurrent driver‐gene alterations, and country were evaluated using correlation, sensitivity, and multivariable analyses. Principal component and regression‐model robustness were additionally assessed.

Results

APOBEC burden varied markedly across tumors (median, 2002 mutations; IQR, 987–4346). Several associations observed using signature proportions were not maintained in absolute‐count analyses: SBS1, SBS3, and SBS5 changed direction, indicating sensitivity to compositional representation. In contrast, SBS18 remained inversely associated with APOBEC‐associated mutagenesis in all variable pairings examined: proportion vs. proportion (Spearman ρ = −0.527), APOBEC proportion vs. SBS18 absolute count ( r = −0.435), and absolute count vs. absolute count (Pearson r = −0.319, p = 1.59 × 10 −14 ; Spearman ρ = −0.317). These are distinct comparisons rather than discrepant estimates. Notably, this cohort‐wide relationship was primarily characterized by higher APOBEC burden in SBS18‐negative than SBS18‐positive tumors rather than a continuous inverse relationship among SBS18‐positive tumors. The multivariable model had an in‐sample R 2 of 0.400 but lower and variable 10‐fold cross‐validated performance (mean R 2 = 0.273). Country added little explanatory information to this model (Δ R 2 = 0.008; global p = 0.402). ZNF750‐mutant tumors had higher APOBEC burden than wild‐type tumors (BH‐FDR q = 0.0032), although only 12 tumors carried ZNF750 alterations.

Conclusion

Genomic correlates of APOBEC‐associated mutagenesis in ESCC are sensitive to the representation of mutational signature activity. SBS18 showed the most consistent inverse association, whereas the ZNF750 association warrants independent validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutagenesisEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsAPOBEC DeaminasesHumansMutationMaleFemale

Stichwörter der Autor:innen

APOBEC mutagenesisSBS18ZNF750esophageal squamous cell carcinomamutational signatureswhole‐genome sequencing

Substanzen

APOBEC Deaminases

Autor:innen und Institutionen

  • Department of Molecular Biology and Biotechnology, University of Cape Coast, Cape Coast, Ghana.
  • Department of Gene Therapy, Thrivus University of Biomedical Science and Technology, Accra, Ghana.
  • Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.

ORCID-Profile: Emmanuel Owusu Ansah, Joshua Ampofo Yentumi

Zitieren

APA

Ansah, E. O., Yentumi, J. A., Kodom, E. Y., Mensah, P. O., Fosu, K., Adu, I. K., & Boahen, E. A. (2026). Genomic Correlates of APOBEC ‐Associated Mutagenesis in Esophageal Squamous Cell Carcinoma. Molecular Genetics & Genomic Medicine, 14(11). https://doi.org/10.1002/mgg3.70345

Vancouver

Ansah EO, Yentumi JA, Kodom EY, Mensah PO, Fosu K, Adu IK, et al. Genomic Correlates of APOBEC ‐Associated Mutagenesis in Esophageal Squamous Cell Carcinoma. Molecular Genetics & Genomic Medicine. 2026;14(11). doi:10.1002/mgg3.70345

BibTeX
@article{Ansah2026,
  author = {Ansah, Emmanuel Owusu and Yentumi, Joshua Ampofo and Kodom, Emmanuel Yeboah and Mensah, Prince Owusu and Fosu, Kwadwo and Adu, Isaac Kofi and Boahen, Emmanuel Adu},
  title = {Genomic Correlates of APOBEC ‐Associated Mutagenesis in Esophageal Squamous Cell Carcinoma},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1002/mgg3.70345}
}
Kostenlos starten →